← Eichor
Study identifier: NCT07195318 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Fisetin Supplementation for Healthy Aging

Condition: Healthy  ·  Sponsor: Ove Andersen

PhaseNA
Planned participants120
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersYes

About this study

There is growing interest among the general population in preventive health interventions that can help mitigate age-related decline, reduce the risk of chronic diseases, and promote healthy aging. The use of nutritional supplements has been increasing and is especially high in older adults and healthier individuals. In response to this demand, a growing number of nutritional supplements are being advertised for their "anti-aging" properties, claiming to target molecular and cellular "hallmarks of aging", such as chronic inflammation, oxidative stress, and cellular senescence. However, the overwhelming majority of these claims stem from preclinical studies in animal models (e.g., C. elegans, mice), and there is extremely limited evidence for beneficial effects, effective doses, or safety profiles of these supplements in humans. Moreover, the lack of strict regulations in the nutritional supplement industry leads to wide differences in the quality and in the actual content of active substances between supplements, which could impact both their efficacy and safety. The investigators will conduct a clinical trial in healthy volunteers, who will receive supplementation with fisetin (100 mg) or placebo daily for 7 weeks. Participants will be examined at regular intervals during the study period. The investigators will then investigate whether fisetin supplementation is safe and evaluate its effect on measures of chronic inflammation, cellular senescence, aging, and general health…

This description comes directly from the study's public registry record.

Talk to the study team

Juliette Tavenier  ·  +45 38620958  ·  juliette.tavenier@regionh.dk

Line Jee Hartmann Rasmussen  ·  +45 38620640  ·  line.jee.hartmann.rasmussen@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Clinical Research, Copenhagen University Hospital Amager & HvidovreHvidovre, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07195318